1. Home
  2. SLNG vs EQ Comparison

SLNG vs EQ Comparison

Compare SLNG & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$4.45

Market Cap

97.4M

Sector

Utilities

ML Signal

HOLD

Logo Equillium Inc.

EQ

Equillium Inc.

HOLD

Current Price

$1.23

Market Cap

89.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
EQ
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.4M
89.4M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
SLNG
EQ
Price
$4.45
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $8.56
AVG Volume (30 Days)
18.8K
★ 452.1K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2400.00
N/A
EPS
★ N/A
N/A
Revenue
★ $68,245,000.00
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$70.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.21
$1.16
52 Week High
$7.07
$6.20

Technical Indicators

Market Signals
Indicator
SLNG
EQ
Relative Strength Index (RSI) 41.01 34.28
Support Level $3.30 $1.16
Resistance Level $5.01 $1.51
Average True Range (ATR) 0.32 0.12
MACD -0.05 0.02
Stochastic Oscillator 15.58 18.57

Price Performance

Historical Comparison
SLNG
EQ

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: